Medicaid work rules are now live. Here is what that means. On May 1, 2026, Nebraska became the first state in the country to enforce Medicaid work requirements under the federal reconciliation law. Here is the core rule: able-bodied adults ages 19 to 64 on Medicaid expansion must now document at least 80 hours per month of qualifying activity, including paid work, school, job training, or volunteering. If they cannot prove it, they risk disenrollment. On paper, most of these adults already qualify. KFF estimates roughly 65% of expansion adults without dependent children already work 80 or more hours per month. So why is this still a major problem? Because the coverage losses are not going to come from people ...

Why are pharma companies betting big on AI clinical trial networks? Iterative Health just closed a massive $77M Series C, led by Google Ventures and Intrepid Growth Partners. The numbers tell an interesting story: → 100+ research sites across 4 continents → 40+ pharma and biotech partnerships → 3x higher patient enrollment rates → 2x faster site activation → 3 months less startup time for trials But here's what caught my attention: They're expanding from GI and hepatology into cardiology and obesity. Two of healthcare's most expensive chronic conditions. Think about this for a moment. The average Phase 3 clinical trial costs $19 million and takes 3.5 years to complete. Patient recruitment accounts for nearly 30% of that timeline. Iterative ...

50 states just got marching orders from CMS. Are you ready? Dr. Mehmet Oz, the new CMS Administrator, just dropped a directive that's about to shake up Medicaid provider networks nationwide. All 50 states must conduct "swift review and revalidation of high-risk providers." The kicker? Any provider without a National Provider Identifier is automatically flagged for review. Here's what this really means: Thousands of providers who've been operating in regulatory gray areas are about to face scrutiny. Rural clinics, behavioral health providers, and smaller practices that never properly enrolled could be cut from Medicaid rolls. The timing is brutal. We're already facing provider shortages. Medicaid patients already struggle to find doctors who accept their insurance. Now we're potentially removing more ...

72 hours to approve or deny. CMS just rewrote the rules. Starting this year, health plans must respond to prior authorization requests within 3 days for urgent cases. Seven days for standard requests. No more black holes. No more endless waiting. The numbers are staggering: 📊 This affects 50% of all Medicare beneficiaries through Medicare Advantage 💰 Impacts 30% to 60% of revenue for Medicare and Medicaid heavy providers ⚡ Requires FHIR based APIs for electronic prior authorization across MA, Medicaid, CHIP, and ACA plans But here's what really matters: Public metric reporting. Every plan must now publish their approval rates, denial reasons, and turnaround times. Transparency as a forcing function. Think about what this means for cancer patients waiting ...

The U.S. just captured 76% of ALL global digital health funding. $5.34 billion in Q1 2026 alone. But here's what's really happening beneath the surface: Deal volume is DOWN, yet average deal sizes MORE THAN DOUBLED. Investors aren't spreading bets anymore. They're going all-in on proven winners. The money is flowing into three specific areas: • Clinical workflow AI that actually integrates • Payer infrastructure that reduces prior auth headaches • Medication access systems that work at scale This isn't about more apps or pilots. It's about infrastructure. Remember when everyone predicted healthcare innovation would democratize globally? The opposite happened. Capital concentrated where regulatory pathways are clearest, where health systems have IT budgets, and where reimbursement models support innovation. Meanwhile, ...

Healthcare AI just pulled in $100M+ this week. Here's who got funded. $77 million to Iterative Health (Series C) $12 million to Lungpacer Medical (Convertible Note) $3 million to TietAI (Seed) $1 million to Depth Health (Seed) These aren't random bets. Look at where the smart money is flowing: 🎯 Clinical AI that actually works 🎯 B2B software replacing broken systems 🎯 Hardware solving real patient problems The standout? Iterative Health's massive Series C. They're not building another chatbot. They're tackling precision medicine with AI that helps gastroenterologists catch early stage diseases. Remember when we hit $29.7 billion in global digital health funding last year? We're on track to beat it. Q1 2026 alone saw $3 billion across 122 deals. ...

What if AI could catch the lung cancer your doctor missed? New data from ARRS 2026 just stopped me in my tracks. An FDA-cleared AI tool called qXR-LN improved detection of missed lung nodules on chest X-rays by 26.7%. Think about that for a second. More than 1 in 4 potentially cancerous nodules that human eyes missed, caught by AI. The stakes couldn't be higher: • Early detection: 56% five-year survival rate • Late detection: 5% five-year survival rate That's not a typo. It's the difference between planning your future and planning your funeral. Here's what really struck me about the study: 73% of the missed nodules were in the upper lobes, the areas radiologists know are most challenging to ...

MRI just became a molecular microscope for your entire body. Philips dropped something game-changing at ISMRM 2026 yesterday: the Titanion MR with 150 mT/m gradient performance. Think about what this means 🔬 We're no longer just looking at anatomy. We're measuring microstructures. Cell density. Tissue characteristics invisible to standard MRI. This isn't incremental improvement, it's a paradigm shift. Traditional MRI: Shows you what's there Titanion MR: Tells you what it's made of The implications for oncology alone are staggering. Imagine detecting cancer not by size, but by cellular behavior. Tracking treatment response through molecular changes before tumors shrink. Personalizing therapy based on tissue microstructure. But here's what excites me most: Quantitative biomarkers across the entire body. No more subjective reads. ...